Patients' satisfaction and safety of bulk injection therapy Urolastic for treatment of stress urinary incontinence: A cross-sectional study
| Autor: | Jan-Paul W. R. Roovers, Sandra E. Zwolsman, Claudia R. Kowalik, Mija Blaganje, Ellen van der Linden, Mateja Lasić Pecev, Claudia Berends, Pieter Minnee, Fenne M. Casteleijn |
|---|---|
| Přispěvatelé: | Graduate School, Obstetrics and Gynaecology, ARD - Amsterdam Reproduction and Development, APH - Methodology, APH - Personalized Medicine, APH - Quality of Care, APH - Digital Health, APH - Aging & Later Life |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Cross-sectional study Urinary Incontinence Stress Urology 030232 urology & nephrology Urinary incontinence 03 medical and health sciences 0302 clinical medicine Quality of life Interquartile range Surveys and Questionnaires Internal medicine Original Clinical Article Humans Medicine Dimethylpolysiloxanes Aged Titanium 030219 obstetrics & reproductive medicine business.industry Urinary retention Injection therapy Satisfaction questionnaire Middle Aged Cross-Sectional Studies Treatment Outcome Satisfaction rate Patient Satisfaction Quality of Life Female Neurology (clinical) medicine.symptom Original Clinical Articles business |
| Zdroj: | Neurourology and urodynamics, 39(6), 1753-1763. Wiley-Liss Inc. Neurourology and Urodynamics |
| ISSN: | 0733-2467 |
| Popis: | Aims Primary outcome was to evaluate patients' satisfaction after being treated with bulk injection therapy polydimethylsiloxane Urolastic (PDMS‐U) for stress urinary incontinence (SUI). Secondary outcomes were: subjective cure, objective cure, severity of SUI symptoms, complications, reintervention rate, and disease‐specific quality of life. Furthermore, to determine if outcomes worsened during time‐after‐treatment (time‐frames: 0‐12, 13‐24, and ≥25 months). Methods In a cross‐sectional design, patients treated with PDMS‐U were recruited for hospital revisit. The primary outcome, patients' satisfaction, was assessed by the surgical satisfaction questionnaire. Subjective cure, objective cure, and severity of symptoms were assessed by the patients global impression of improvement, standardized cough stress test, and Sandvik severity scale, respectively. Medical charts and face‐to‐face interviews were used to determine complications and reinterventions. Results About 110 patients participated, 87 revisited the hospital. Median follow‐up was 25 months (interquartile range: 14;35 months). Patients' satisfaction rate was 51%. Subjective and objective cure were respectively 46% and 47%. Most prevalent complications were: urinary retention (22%), pain (15%), and dyspareunia (15%). Exposure and erosion occurred in 7% and 5%, respectively. Reintervention rate of reinjection and excision of bulk material was 6% and 18.0%, respectively. Objective cure significantly worsened during time‐after‐treatment (P = |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text